TGR Biosciences
31 Dalgleish Street
Adelaide
South Australia
5031
Tel: 61-8-8354-6170
Fax: 61-8-8354-6188
Website: http://www.tgr-biosciences.com.au/
Email: info@tgr-biosciences.com.au
9 articles about TGR Biosciences
-
Expedeon AG adds ELISA-ONEā¢ next generation cell signalling assay technology to product offering
5/8/2019
Technology developed by Expedeon company TGR BioSciences
-
Expedeon AG (formerly SYGNIS AG) reports financial results for the first six months of 2018 and successful execution of name change
8/9/2018
Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) today reported results for the second quarter of 2018 and six-month period ended 30 June 2018. In addition, the Company has officially completed the change of name to Expedeon AG from SYGNIS AG.
-
Innova Biosciences And TGR Biosciences Announce Co-Marketing Agreement For Core Technologies
1/16/2014
-
TGR Biosciences Announces License Agreement With Abcam plc
9/23/2013
-
Company Profile for TGR Biosciences
12/17/2010
-
TGR Biosciences Announces Distribution Partnership with Cedarlane Corporation
12/14/2010
-
TGR Biosciences Announces Distribution Partnership with Cedarlane Corporation
12/13/2010
-
TGR Biosciences Announces Expansion of its 'No-Wash' SureFire(R) Cellular Kinase Assay Portfolio
5/3/2010
-
Innocoll, Inc. Enters Into Collaboration With TGR Biosciences for Development of a Novel Wound Healing Product
9/12/2007